About

IMGT is an innovative medical device company
Creating new treatment possibilities through focused ultrasound.

IMGT develops novel therapeutic solutions powered by focused ultrasound. Our treatment platform is designed to move
Beyond the limits of conventional care and open new possibilities across a range of therapeutic areas.

Mission

Beyond Treatment Limits, Back to Everyday Life.

We work to expand treatment options and give patients better opportunities to return to a healthy, active life.

Vision

A New Treatment Paradigm with Focused Ultrasound

We work toward a future where focused ultrasound offers a safer, more effective, non-invasive treatment option.

Current Therapeutic Areas

We continue to expand the therapeutic potential of focused ultrasound.

  • Pain Management Targeted Ultrasound
    Stimulation
  • Cancer Treatment ChemoSono Therapy®
    ImmunoSono Therapy
  • Tissue Regeneration Targeted Ultrasound
    Stimulation

History

2023~2026

2026
  • 07FDA IMD10 IDE Amendment Approval
  • 01Central IRB IMD10 Pivotal Trial Approval
  • 01MFDS IMD10 Innovative Medical Device Designation
2025
  • 11Dongbang Medical FUS Product Development Agreement
  • 11FDA IMD10 Pivotal Trial IDE Approval & Category B Designation
  • 09Final CSR for the IMD10 Exploratory Clinical Trial
  • 04ADD Future Challenge Defense R&D Program (USD 9.8M)
  • 04Series D Funding (USD 10.6M)
  • 02Pan-Ministerial Medical Device R&D Program – Top 10 Project
  • 02FDA IMD10 Breakthrough Device Designation (BDD)
2024
  • 11IR52 Jang Young-shil Technology Innovation Award
  • 11MOTIE Biohealth R&D Outstanding Researcher Commendation
  • 09ESMO 2024 IMD10 Exploratory Trial Interim Results
  • 05New Excellent Technology (NET) Certification
  • 04MSIT Ministerial Commendation
2023
  • 12MSIT Excellent Corporate R&D Center Designation
  • 11MFDS IMD20 Exploratory Trial IDE Approval
  • 07MOTIE Materials&Components R&D Program (USD 14.9M)
  • 07KONEX Listing

2020~2022

2022
  • 107th Lee Min-hwa Medical Entrepreneurship Award
  • 08MFDS IMD10 Exploratory Trial IDE Approval
  • 07ISO 9001:2015 Certification
  • 01MOTIE Bioindustry Technology R&D Program (USD 3.1M)
  • 03Scale-up TIPS Program (USD 1.5M)
2021
  • 11Series C Funding (USD 11.2M)
  • 08IMGT-FUS Clinical GMP Certification
2020
  • 11Series B2 (Bridge) Funding (USD 2.8M)
  • 09Pan-Ministerial Medical Device R&D Project (USD 5.0M)

2010~2019

2019
  • 06Office Relocation to SNUBH Healthcare Innovation Park
2018
  • 12Series B Funding (USD 7.3M)
2016
  • 12Series A Funding (USD 1.4M)
  • 10Corporate R&D Center Establishment
2015
  • 11MOHW Advanced Medical Tech R&D Program (USD 0.14M)
  • 10TIPS Program (USD 0.22M)
2010
  • 10Venture Company Certification
  • 04IMGT Co., Ltd. Establishment

Leadership

Executive Team

  • Hak Jong Lee Founder & CEO

    • ◦ SNUBH – Professor, Department of Radiology
    • ◦ SNUBH – Director, Biomedical Research Institute
    • ◦ SNUBH – Director, Medical Device R&D Center
    • ◦ Korean Society for Therapeutic Ultrasound
    • – Vice President
  • Keon Ho Son CEO & CTO

    • ◦ Alpinion Medical Systems – Managing Director,
    • Therapeutic Ultrasound Division
    • ◦ Siemens Korea – Research Fellow,
    • Ultrasound Research Center
    • ◦ Samsung Medison – Senior Researcher
  • Denny Park COO Vice President

    • ◦ DRGEM – General Manager, China Subsidiary
    • & Head, Management Support Department
    • ◦ MCS Logic – CFO & Hong Kong JV Representative
    • ◦ Woori Bank – International Finance Division
    • ◦ CJ CheilJedang – Finance Team
  • Su Hee Kim CCRO Managing Director

    • ◦ Peptron — Head, Clinical Research
    • ◦ Korea United Pharm — Head, Clinical Research
    • ◦ Roche Diagnostics Korea – Head,
    • Medical & Scientific Affairs
    • ◦ Johnson & Johnson Medical Korea –
    • Clinical Research Manager
  • Ji Seob Jun Managing Director

    • ◦ Alpinion Medical Systems – Principal Researcher
    • ◦ Siemens Healthineers Korea – Principal Researcher
    • ◦ Samsung Medison – Senior Researcher
  • Ho Seong Shim CSO Director

    • ◦ ImaGoworks – COO
    • ◦ Innerbottle – COO
    • ◦ Boston Consulting Group(BCG) – Consultant
    • ◦ Samsung Electronics – Marketing Manager,
    • Medical Device Business

Advisory Board

  • Seung Ho KangProfessor

    • ◦ Yonsei University – Professor of Applied Statistics
    • ◦ FDA – NCTR Postdoctoral Researcher;
    • CDER Visiting Professor
    • ◦ MFDS – Statistical Advisor, Medical Devices
    • ◦ 100+ Clinical&Regulatory Statistical Consulting
    • ◦ University of Wisconsin–Madison – Ph.D., Statistics
  • Chung Keun LeeProfessor

    • ◦ SNUBH – Research Professor, Medical Device R&D
    • ◦ MFDS – Medical Device Reviewer
    • ◦ AI-Based Medical Device Regulatory Review &
    • Clinical Trial Guidelines
    • ◦ Research on 1,500+ Medical Device Clinical Trial
    • Approvals in Korea
    • ◦ Yonsei University – Ph.D., Electrical Engineering

IMGT CI

Download Logo

Color

IMGT blue represents trust, expertise, and advanced medical technology.

Clear Blue
RGB
0 116 200
HEX
#0074C8
CMYK
100 42 0 22
Light Blue
RGB
122 166 220
HEX
#7AA6DC
CMYK
45 25 0 14
TOP